Clinical Trials for Meiji Seika Pharma

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Meiji Seika Pharma

Clinical Trials (1)

NCT05905055
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
PHASE3Recruiting
150 participants
Started: Sep 22, 2023 · Completed: Sep 30, 2025
5 conditions1 sponsor1 location